Hans Biomed Corp.

Hans Biomed Corp.
Stock Exchange Korea Exchange
EPS
KRW708
Market Cap
KRW295.24 B
Shares Outstanding
9.86 M
Public Float
6.88 M

Profile

Address
7 Jeongui-ro 8-gil
Seoul SL 05836
Korea, Republic Of
Employees -
Website http://www.hansbiomed.com
Updated 09/14/2018
HansBiomed Co., Ltd. engages in the manufacture and sale of graft material and silicon products. Its products include skin and bone graft material, silicon material, and other medical appliances. The company was founded on September 15,1999 and is headquartered in Seoul, South Korea.

Financials

View All

Ho-Chan Hwang
Chief Executive Officer & Director
Won-Gyun Kwon
Director & Head-Research